The Bruker Energy & Supercon Technologies (BEST) division, a segment of Bruker Corporation (Nasdaq: BRKR), today announced ...
November 30, 2006 (Chicago) -- Magnetic resonance spectroscopic imaging (MRSI) shows no advantages over magnetic resonance imaging (MRI) alone for localization of peripheral zone prostate cancer in ...
WEST LAFAYETTE, Ind. — The same technology behind MRI images of injury or disease also powers nuclear magnetic resonance (NMR) spectroscopy, which is used to analyze biological molecules for research ...
Diffusion MRI and MR spectroscopy can predict neurodevelopmental outcomes in newborns with encephalopathy, aiding in early intervention and care planning Mild hypoxic-ischemic encephalopathy and mild ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Imatinib (STI571) plus hydroxyurea: Safety and efficacy in pre-treated, progressive glioblastoma multiforme (GBM) patients (pts) No significant financial relationships to disclose. This is an ASCO ...